These in vitro findings support the computational predictions and suggest that KIR2DL4 may play a tumor-promoting role in melanoma.<h4>Conclusion</h4>This study provides a robust immune-related prognostic model for melanoma. Here, KIR2DL4 is linked to neoplasm.